secwatch.observer — SEC 8-K summary
======================================

Issuer:     Statera Biopharma, Inc. (—)
CIK:        0001318641
Form:       8-K
Filed at:   2023-02-01T23:59:59+00:00
Accession:  0001437749-23-002260
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Statera declares Series B Preferred dividend with super-voting rights for share increase and reverse split
--------------------------------------------------------------------------------

- Declared dividend of 1/1,000th share of Series B Preferred per common share; record date Feb 1, 2023.
- Series B carries 1,000 votes per share, voting only on Authorized Share Increase (150M to 250M) and Reverse Split (1-for-10 to 1-for-300).
- Unvoted Series B shares automatically redeemed before meeting at $0.005 per whole share (with rounding exclusions).
- Bylaws amended to reduce stockholder quorum from majority to 33.34% of votes entitled to be cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1318641/000143774923002260/0001437749-23-002260-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1318641/000143774923002260/cbli20230131_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-002260

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer